Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 7Hematologic Neoplasms 7Graft vs Host Disease 5Gliosarcoma 5Glioblastoma 5Brain Neoplasms 5Prostatic Neoplasms 4Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 4Waldenstrom Macroglobulinemia 3Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myeloid, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Hodgkin Disease 3Carcinoma, Non-Small-Cell Lung 3Tuberous Sclerosis 2Oligodendroglioma 2Neurofibrosarcoma 2Myeloproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma 2Lung Neoplasms 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Glioma 2Burkitt Lymphoma 2Bronchiolitis Obliterans Syndrome 2

Interventions

Dexamethasone 8Cytarabine 7Cyclophosphamide 7venetoclax 6Vincristine 6Methotrexate 5merphos 4Rituximab 4Prednisone 4pegaspargase 3fludarabine phosphate 3dexamethasone acetate 3dexamethasone 21-phosphate 3Peripheral Blood Stem Cell Transplantation 3Filgrastim 3Calcium Dobesilate 3ruxolitinib 2prednylidene 2nelarabine 2deltacortene 2auricularum 2Whole-Body Irradiation 2Specimen Handling 2Pentetic Acid 2Mycophenolic Acid 2Injections 2Granulocyte Colony-Stimulating Factor 2Everolimus 2Etoposide 2Decitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Sirolimus × Clear all
NCT00776373 2025-11-05

UPCC 25406

Abramson Cancer Center at Penn Medicine

Phase 1/2 Terminated
4 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡